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Background: Most studies on blood donors are centered on the selective evaluation of red 
blood cell parameters with little or no regard to white blood cells and platelets.
Methods: One hundred and twelve male blood donors comprising 43 first-time and 69 regular 
blood donors, drawn from a tertiary health facility in the Niger Delta of Nigeria, participated in the 
study. Their hematological parameters were assessed using a 3-part differential   autohematology 
analyzer (PCE-210 N).
Results: Of the blood donors, 18.8% were found to be anemic (packed cell volume 
[PCV] ,33%) while 12.5% were leukopenic (white blood cell [WBC] count ,2.0 × 109/L). 
The leukopenia observed in this study was largely due to the significant reductions in both the 
absolute lymphocyte (P = 0.019), percent lymphocyte (P = 0.016), and percent monocyte count 
(P = 0.008). Anemia was obviously due to the reduction in the red blood cell (RBC) count,   
PCV , hemoglobin (Hb), mean cell Hb (MCH), and red cell distribution width (RDW) values. 
Significant positive correlations were found between PCV and total WBC count (r = 0.309; 
P , 0.01) while a negative correlation was found between PCV and absolute lymphocyte counts 
(r = -0.191; P , 0.005) and RDW (r = -0.219; P , 0.05). Comparison of the mean values of the 
first-time versus regular blood donor parameters revealed that six parameters were significantly 
reduced in the regular blood donors (PCV , absolute WBC count, percent monocytes, RBC count, 
Hb, PCV). The reference ranges of hematological parameters for Port Harcourt donors are also 
presented in this study. No thrombocytopenia was observed.
Conclusion: Regular blood donation not only affects red cell parameters but also those of white 
cells. Subclinical leukopenia is present among regular blood donors in this locality. First-time 
blood donors would be most preferable when the concentrated white blood cell component of 
blood needs to be prepared.
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Introduction
Blood donation is an essential part of blood transfusion services. In 1997, the World 
Health Organization set a target for all blood donors to be unpaid volunteers.1
In most countries, strict regulations have been established for the selection of blood 
donors that incorporate criteria that serve to protect both the donor and recipient,2 
but these regulations are not adhered to in most developing countries, including 
Nigeria. An acceptable frequency of donation is normally two or three times a year 
or every 12 weeks.3 The effect of frequent blood donation on body iron stores has 
been   studied exhaustively, with very similar findings for iron deficiency and iron 
deficiency anemia.4–6Journal of Blood Medicine 2011:2 submit your manuscript | www.dovepress.com
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Voluntary unpaid blood donation is a humanitarian act 
by the healthy to benefit the sick. Commercial donors com-
monly masquerade as family replacement donors and thus 
may donate blood more frequently than they should. Since 
no blood transfusion service can survive without blood 
donors, the well-being and health of blood donors is an issue 
of prime importance.
Much emphasis has been laid on iron deficiency, probably 
because of anemia which reduces maximum oxygen con-
sumption and maximum work performance in proportion to 
its severity. Since whole blood is composed of three cellular 
elements (red blood cells, white blood cells, and platelets), 
parameters other than red blood cells (RBCs) also need to 
be assessed, which is the aim of this study.
Materials and methods
study population
The subjects comprised 120 unselected consecutive whole 
blood donors comprising regular and first-time donors. 
The first-time donors were mostly patient relatives who were 
donating blood for the first time. The regular donors had 
donated blood three to four times prior to the time of collec-
tion of study samples. The subjects comprised 112 males and 
only 8 females. The female group was therefore excluded 
from the study population because of their small number. 
The male donors were randomly selected as long as they 
were eligible for blood donation based on their packed 
cell volume (PCV) at a cut-off value of 33%. Age of blood 
donors ranged from 20 to 60 years. The study was conducted 
at the blood bank of the University of Port Harcourt Teach-
ing Hospital, Port Harcourt, Nigeria. Donors were bled in 
the phlebotomy unit after receiving their informed consent. 
The study received ethical approval from the Hematology 
department of the same hospital. The survey was conducted 
between January and May 2010.
sample collection
Three milliliters of blood was collected into an EDTA bottle. 
Blood samples were analyzed the same day or the next day 
depending on the time of collection (donors who came later 
in the day had their samples analyzed the next day). Samples 
held overnight were refrigerated at 2°C to 8°C.
sample analysis
Samples were analyzed with a hematology auto analyzer 
(PCE-210 N; Erma, Inc, Tokyo, Japan), a fully automatic 
blood cell counter that measures 18 blood component 
  parameters including three white blood cell (WBC) 
  components (lymphocytes, granulocytes and monocytes). 
Procedures were performed according to the standard oper-
ating manual.
statistics
Data were analyzed using SPSS software (v 16; SPSS, Inc, 
Chicago, IL). Descriptive statistics for means, standard 
deviation, median, and 95% confidence interval were used. 
Student’s t-test was used for the comparison of means 
between two groups. Probability value was set at alpha 0.05. 
Values #0.05 were regarded as statistically significant.
Results
Donors . 40 years of age (57.1%) were most highly repre-
sented, with regular donors dominating the study population 
(61.6%) (Table 1); 84.8% of donors were O blood group and 
92.0% were RhD positive.
Table 2 shows reference ranges of hematological param-
eters in relation to age groups and donor categories. Signifi-
cant reductions were observed in the following parameters 
for regular blood donors: PCV (P = 0.001), WBC count 
(P = 0.02), other white cells (%) (P = 0.005), RBC count 
(P = 0.012), Hb (P = 0.001), and mean corpuscular volume 
(MCV) (P = 0.03). No significant changes were observed for 
the other parameters (Table 3).
Of the 112 blood donors, 21 (18.8%) were anemic 
(PCV of #33%) (Table 4). Circulating lymphocytes 
(%), granulocytes, and other white cells (monocytes) 
were significantly lower in the anemic group (P = 0.005, 
P = 0.02, P = 0.016, respectively). Total WBCs declined 
significantly from 4.1 ± 1.8 × 109/L in the anemic group 
(P = 0.047).   Similarly, RBC, Hb, and mean cell Hb (MCH) 
Table 1 characteristics of the male blood donors
Variables Number Percentage (%)
Age (years)
  ,30 29 25.9
  30–40 19 17.0
  .40 64 57.1
category of donors
  First time 43 38.4
  regular 69 61.6
ABO blood group
 A 8 7.2
 B 9 8.0
  AB 0 0
 O 95 84.8
rhesus blood group
  rhD negative 9 8.0
  rhD positive 103 92.0Journal of Blood Medicine 2011:2 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
81
hematological indices and blood donation
Table 2 reference ranges of the hematological values of the 112 blood donors in relation to their age groups
Parameters Age groups (years)
,30 (n = 29) 30–40 (n = 19) .40 (n = 64)
Mean (SD); 95% CI Mean (SD); 95% Cl Mean (SD); 95% Cl
PcV (%) 38.0 (4.0); 36.5–39.6 36.0 (7.8); 36–40 39.4 (4.9); 37–41.7
WBc (×109/L) 3.9 (1.9); 3.2–4.6 3.9 (1.9); 3.4–4.3 4.1 (1.8); 3.2–4.9
Lymphs (abs) 2.3 (0.9); 1.9–2.7 2.2 (0.07); 1.9–2.4 2.1 (0.8); 1.7–2.5
Lymphs (%) 46.4 (10.0); 42.6–50.3  51.1 (13.6); 47.7–54.5 49.0 (9.1); 44–53.4
granulocytes (abs) 1.9 (0.9); 1.6–2.3  3.5 (3.1); 0.2–6.8  1.9 (0.8); 1.5–2.3 
granulocytes (%) 44.5 (11.2); 40.2–48.8 39.6 (11.4); 36.7–42.4 42.1 (11.1); 36.7–47.5
Monocytes (abs) 0.7 (0.5); 0.4–0.9 0.7 (0.6); 0.5–0.8  0.5 (0.5); 0.2–0.8
Monocytes (%) 7.7 (2.9); 6.6–8.9 8.5 (5.2); 7.2–9.8 8.1 (3.8); 6.2–9.9
rBc (×1012/L) 5.1 (1.1); 4.6–55 5.0 (1.3); 4.7–54 5.4 (0.9); 4.9–5.8
hb (g/dL) 13.2 (2.0); 12.4–13.9 12.9 (3.0); 12.2–13.7  13.2 (2.0); 12.2–14.2
McV (fL) 73.4 (8.8); 70.1–76.8 71.3 (11.6); 68.4–74.2  71.3 (11.4); 65.8–76.9
Mch (pg) 22.7 (4.2); 21–24.3 22.4 (94.2); 21.3–23.4  23.9 (4.0); 65.8–76.9
Mchc (g/dL) 30.2 (4.0); 28.4–32.0  34.0 (4.0); 23–44 31.1 (3.9); 29.2–33.0
rDW (%) 16.5 (2.2); 15.7–17.4 18.1 (4.1); 17.1–19.1 16.4 (2.3); 15.3–17.5
PLT (×109/L) 218.1 (74.9); 189.6–246.6 249.4 (110.1); 221–276.9 232 (79.4); 193–270.4
MPV (%) 7.5 (1.4); 7.0 7.4 (1.7); 7.0  7.5 (1.6); 6.7
PDW (%) 36.3 (7.6); 33.4–39.2 35.8 (9.5); 33.4–38.1 39.0 (10.9); 33.7–44.3
Abbreviations: CI, confidence interval; Hb, hemoglobin; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; MCV, mean corpuscular volume; 
MPV, mean platelet volume; PcV, packed cell volume; PDW, platelet distribution width; PLT, platelets; rBc, red blood cell; rDW, red cell distribution width; sD, standard 
deviation; WBc, white blood cell.
Table 3 Comparison of mean values of first-time and regular blood donors
Parameters  First time (n = 43) Regular (n = 69)  t-value P-value
Mean ± SD (range) Mean ± SD (range)
PcV (%) 41.0 ± 7.1 30.5 ± 5.5  3.642 0.001***
WBc (×109/L) 4.4 ± 1.7 3.6 ± 1.8  2.367 0.02*
Lymphs (abs)  2.3 ± 0.9 2.1 ± 0.9  0.677 0.50ns
Lymphs (%)  4.3 ± 1.0 1.9 ± 1.1  1.249 0.110ns
granulocytes (abs) 48.0 ± 11.8 50.5 ± 12.3 1.050 0.296ns
granulocytes (%) 41.8 ± 12.1 40.9 ± 11.1 0.386 0.701ns
Monocytes (abs) 0.6 ± 0.5 0.6 ± 0.6  0.155 0.07ns
Monocytes (%) 9.7 ± 4.6 7.3 ± 4.0  2.883 0.005**
rBc (×1012/L) 5.5 ± 1.2 4.9 ± 1.1  2.565 0.012**
hb (g/dL) 14.1 ± 3.1 12.4 ± 2.0 3.431 0.001***
McV (fL) 74.7 ± 9.6 70.1 ± 11.3  2.194 0.03**
Mch (pg) 23.6 ± 3.6 22.1 ± 4.4  1.867 0.06ns
Mchc (g/dL) 34.0 ± 4.0 30.1 ± 4.0 0.658 0.513ns
rDW (%) 17.0 ± 3.4 17.7 ± 3.6  0.94 0.34ns
PLT (×109/L) 220.1 ± 98.2  249.7 ± 96.0  1.570 0.119ns
MPV (%) 7.6 ± 1.2  7.4 ± 1.8  0.423 0.673
PDW (%) 36.8 ± 10.0  36.2 ± 8.9  0.345 0.731ns
Abbreviations: hb, hemoglobin; Mch, mean cell hemoglobin; Mchc, mean cell hemoglobin concentration; McV, mean corpuscular volume; MPV, mean platelet volume; PcV, 
packed cell volume; PDW, platelet distribution width; PLT, platelets; rBc, red blood cell; rDW, red cell distribution width; sD, standard deviation; WBc, white blood cell.
was   significantly lower while the red cell distribution 
width (RDW) was significantly higher in the anemic group 
(P = 0.001).
Subclinical leukopenia in this study was defined using a 
cutoff value of total WBC count (absolute) of ,2.0 × 109/L. 
Fourteen (12.5%) of the study population were leukopenic. 
PCV (P = 0.001), WBC count (P = 0.001), absolute 
 lymphocytes (P = 0.019), percent lymphocytes (P = 0.016), 
percent granulocytes (P = 0.05), percent monocytes 
(P = 0.0080), RBC (P = 0.014), Hb (P = 0.002), MCH 
(P = 0.001), and mean platelet volume (MPV) (P = 0.005) 
were significantly lower in leukopenic donors (Table 5).
Significant negative correlations were found between 
PCV and absolute lymphocytes (r = 0.191), PCV and RDW Journal of Blood Medicine 2011:2 submit your manuscript | www.dovepress.com
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Table 4 hematological changes in anemic blood donors
Parameters  Anemic Nonanemic t-value  P-value
n = 21 n = 91
Mean ± SD  Mean ± SD 
PcV (%) 30.0 ± 4.5  40.1 ± 5.4 7.932 0.001**
WBc (×109/L) 3.2 ± 1.6 4.1 ± 1.8 2.008 0.047*
Lymphs (abs)  2.1 ± 1.0 2.2 ± 0.9 0.661 0.510
Lymphs (%)  56.1 ± 16.5 48.0 ± 10.4 2.835 0.005**
granulocytes (abs)  1.6 ± 0.9 3.1 ± 1.1 0.620 0.536
granulocytes (%)  36.0 ± 14.7 42.5 ± 10.3 2.360 0.02*
Monocytes (abs)  0.5 ± 0.4  0.6 ± 0.6  1.264 0.209
Monocytes (%)  6.1 ± 2.5 8.7 ± 4.7 2.452 0.016*
rBc (×109/L) 4.1 ± 1.2 5.3 ± 1.1 4.604 0.001**
hb (g/dL) 10.5 ± 1.9 13.6 ± 2.4 5.393 0.001**
McV (fL) 74.9 ± 9.2 71.2 ± 11.1 1.405 0.163
Mch (pg) 20.7 ± 4.2 23.2 ± 4.0 2.447 0.016*
Mchc (g/dL) 26.8 ± 4.8 3.8 ± 3.5 0.954 0.342
rDW (%) 19.8 ± 4.4 16.9 ± 3.0 3.557 0.001**
PLT (×109/L) 255.0 ± 112.6 234.5 ± 93.9 0.870 0.386
MPV (%) 7.9 ± 2.4 7.4 ± 1.4 1.224 0.224
PDW (%) 34.3 ± 10.2     36 ± 9.11 1.149 0.253
Notes: *Significant at P , 0.05; **significant at P , 0.01.
Abbreviations: hb, hemoglobin; Mch, mean cell hemoglobin; Mchc, mean cell 
hemoglobin concentration; McV, mean corpuscular volume; MPV, mean platelet 
volume; PcV, packed cell volume; PDW, platelet distribution width; PLT, platelets; 
rBc, red blood cell; rDW, red cell distribution width; sD, standard deviation; 
WBc, white blood cell.
(r = -0.219), WI3C and percent lymphocytes (r = 0.285), 
WBC and other white blood cells (monocytes) (r = 0.330), 
and MCV and platelet count (r = 0.309). MCH was correlated 
negatively with RBC (r = 0.226), platelets (r = -0.347), and 
MPV (r = -0.240) (Table 6). MPV was correlated nega-
tively with absolute granulocytes (r = -0.288) and percent 
granulocytes (r = -0.316). None of the blood donors were 
thrombocytopenic at a cutoff value of 100 × 109/L.
Discussion
This study describes the reference ranges of hematology 
parameters in blood donors and the effect of regular blood 
donation on these parameters. Reference ranges were estab-
lished using samples derived from anonymous blood donors. 
Out of the 120 blood donors, only 8 (6.6%) were females. 
Because this ratio fell outside the Clinical Laboratory Stan-
dard Institute (CLSI) guidelines of 120 subjects,7 females 
were excluded from the analysis. The lower proportion of 
females is likely due to their less frequent participation in 
blood drives and other medical research because of cultural 
issues. Hematology ranges derived in this study were com-
parable to published values in other African countries.8,9 
This study presents the reference values for males only for 
the reason mentioned above. Since most donors are males, it 
is necessary for their   reference ranges to be established in a 
given locality in order to assist in the donor selection proce-
dures. RBC parameters and platelet findings were consistent 
with those of other published   African countries.5,8–11
In this study, the RBC parameters PVC, RBC count, Hb, 
and MCV values of the regular blood donors were signifi-
cantly lower than those of first-time blood donors. Also, the 
proportion of apparently healthy blood donors who were 
anemic accounted for 21/112 (18.8%) at a cutoff value of 
Hb , 11.0 g/dL. This proportion was slightly higher than the 
13.7% reported recently by Jeremiah and Koate.5 Similarly, 
the findings of this study are consistent with those of Jeremiah 
and Koate,6 in that the hematological parameters of Hb, PCV , 
and MCH concentration were all lower in the regular donors 
than in the other categories of donors.
The difference in these findings is probably due to the 
different study locations: the University of Port Harcourt 
Teaching Hospital and the Braithwaite Memorial Specialist 
Hospital. Despite the differences in the prevalence of anemia, 
it has been established that prevalence of anemia is high in 
Port Harcourt regular blood donors. The implication of this 
finding is that these categories of blood donors are likely to 
compromise their iron stores due to frequent blood donation 
and thus become iron deficient. Jeremiah and Koate5 estab-
lished the presence of both iron deficiency (20.6%) as assessed 
by serum ferritin level (,l2 ng/mL) and iron deficiency 
  anemia (12.0%) as assessed by Hb (,11.0 g/dL + serum 
ferritin ,12 ng/mL). It could be deduced that most of our 
regular blood donors are iron deficient, which is not condu-
cive for a supply of good quality blood.
A typical whole blood donation is the equivalent of 
burning approximately 650 calories. The donated plasma is 
replaced after two to three days, while RBCs are replaced by 
bone marrow into the circulatory system at a slower rate, an 
average of 36 days in healthy adult males. These replacement 
rates are the basis of how frequently a donor can give blood.12 
The exact rate of how often a donor can donate blood differs 
from country to country. RBCs are the limiting step for whole 
blood donations and the frequency of donation permitted var-
ies widely: Hong Kong 3 to 6 months,13 Australia 12 weeks,14 
the United States 12 weeks,15 and the UK usually 16 weeks.16 
In Nigeria, it is not yet established how often a blood donor 
can give blood. With the reference values established and 
the prevalence of anemia known, how many times a donor 
can give blood in Nigeria needs to be defined.
A donor generally donates approximately 450 mL of 
blood at the time of donation. One gram of Hb contains 
3.4 mg of iron. In a normal individual with 15 g/dL of Hb, Journal of Blood Medicine 2011:2 submit your manuscript | www.dovepress.com
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Table 5 hematological changes in leukopenic blood donors
Parameters  Leukopenic Nonleukopenic t-value P-value
n = 14 n = 98
Mean ± SD Mean ± SD
PcV (%) 32.7 ± 6.1 39.0 ± 6.2 3.502 0.001**
WBc (×109/L) 1.2 ± 0.5 4.3 ± 1.6 7.141 0.001**
Lymphs (abs) 1.6 ± 0.9 2.3 ± 0.9 2.376 0.019*
Lymphs (%) 2.2 ± 1.7 2.9 ± 1.5 0.276 0.781
granulocytes (abs) 55.8 ± 20.1 48.5 ± 10.0 2.447 0.016*
granulocytes (%) 35.9 ± 19.1 42.0 ± 9.8 1.905 0.05*
Monocytes (abs) 0.6 ± 0.7 0.7 ± 0.6 0.178 0.859
Monocytes (%) 5.2 ± 2.3 8.6 ± 4.5 2.702 0.01*
rBc (×1012/L) 4.3 ± 1.2 5.2 ± 1.2 2.492 0.014*
hb (g/dL) 11.0 ± 2.5 13.3 ± 2.5 3.153 0.002**
McV (fL) 68.1 ± 11.3 72.4 ± 10.7 1.390 0.167
Mch (pg) 18.1 ± 2.7 23.4 ± 3.9 4.768 0.001**
Mchc (g/dL) 25.8 ± 4.9 33.5 ± 3.2 0.853 0.396
rDW (%) 18.2 ± 2.9 17.3 ± 3.6 0.853 0.396
PLT (×109/L)  226 ± 72.1 240.1 ± 100.8 0.492 0.624
MPV (%) 8.6 ± 2.4 7.3 ± 1.4 2.868 0.005**
PDW (%) 37.4 ± 8.7 36.3 ± 9.4 0.415 0.192
Notes: *Significant at P , 0.05; **significant at P , 0.01.
Abbreviations: hb, hemoglobin; Mch, mean cell hemoglobin; Mchc, mean cell hemoglobin concentration; McV, mean corpuscular volume; MPV, mean platelet volume; PcV, 
packed cell volume; PDW, platelet distribution width; PLT, platelets; rBc, red blood cell; rDW, red cell distribution width; sD, standard deviation; WBc, white blood cell.
Table 6 Observed positive correlations of the various hemato-
logical parameters using Pearson’s correlation test
Parameters correlated Correlation coefficient (r)
PcV  vs TWBc 0.309**
vs Lymphs (abs) -0.191*
vs hb 0.895**
vs rBc 0.637**
vs rDW -0.219*
vs PDW 0.218*
WBc  vs Platelets 0.276**
vs Lymphs (abs) 0.444**
vs Lymphs(%) 0.285**
vs Monocytes (abs) 0.330**
vs Monocytes (%) 0.496**
vs hb 0.303**
vs rDW 0.189*
McV  vs Platelets 0.309**
vs MPV 0.236*
Mch  vs PcV 0.269**
vs rBc 0.226*
vs hgB 0.266**
vs Platelets 0.347**
vs MPV 0.240*
MPV  vs granulocytes (abs) 0.288**
vs Lymphocytes (abs) 0.267**
vs granulocytes (%) -0.316**
vs Mchc 0.190*
Notes: **Correlation significant at P , 0.01; *correlation significant at P , 0.05. 
Abbreviations: hb, hemoglobin; Mch, mean cell hemoglobin; Mchc, mean cell 
hemoglobin concentration; McV, mean corpuscular volume; MPV, mean platelet 
volume; PcV, packed cell volume; PDW, platelet distribution width; PLT, platelets; 
rBc, red blood cell; rDW, red cell distribution width; sD, standard deviation; 
TWBc, total white blood cell.
100 mL of blood contains approximately 50 mg of iron. 
Thus, removal of only 2 mL of blood results in a 1 mg loss 
of iron.17 If 450 mL of blood are taken in a donation, approxi-
mately 225 mg of iron will be lost. If the donor has no iron 
deficiency, the RBCs and the Hb level will gradually return 
to normal within 3 to 4 weeks. Hence adequate iron stores 
are very important in the maintenance of donor health.18 An 
acceptable frequency of donation is normally two to three 
times a year. In this study, all the regular donors had already 
donated two to three times within 3 months, because most 
of the blood donors always hide their identity and come in 
the guise of a patient relation to donate blood. This study 
did not estimate serum ferritin to define iron deficiency but 
the most recently published data indicate that most of these 
blood donors are iron deficient. Iron is a universal cofac-
tor for mitochondrial energy generation and supports the 
growth and differentiation of all cell types. Systemic iron is 
regulated through the proteins transferrin (iron mobilization) 
and ferritin (iron sequestration). The physiologic importance 
of iron storage is that it provides a rapidly available supply 
in the event of blood loss. Serum ferritin concentration is 
an indicator of mobilizable body iron stores,19,20 and as such 
should be incorporated in donor screening.
Another significant and novel finding in this study is 
the prevalence of subclinical leukopenia of 12.5%, which 
has never been reported before. The leukopenia was caused Journal of Blood Medicine 2011:2 submit your manuscript | www.dovepress.com
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largely by a significant reduction in absolute lymphocyte 
counts as well as circulating lymphocytes. Granulocytes did 
not show any significant reduction between leukopenic and 
nonleukopenic groups. Circulating monocytes were equally 
reduced significantly in number in the leukopenic group while 
some red cell parameters such as PCV , RBC, Hb, and MCH 
exhibited significant changes. Mean platelet volume in the 
leukopenic group was also significantly reduced. The reason 
for this leukopenia is not yet understood, especially as the 
process of erythropoeisis and leukopoesis does not originate 
from a common progeny. Whole blood transfusion usually 
means substitution of RBCs of the recipient from the donor. 
We are only concerned about the RBCs and not WBCs and 
platelets, probably because the life span for RBCs (which is 
120 days) is long enough for them to be stored whereas the 
life span of WBCs and platelets is shorter.
For component preparation, concentrated WBCs or plate-
lets can be prepared from pooled multiple donors, as is the 
current practice. Since subclinical leukopenia was observed 
in regular blood donors in this study, first-time donors must be 
the preferred donors for a greater yield of leukocytes. Herein 
lies the importance of this study. Choice of voluntary donors 
and first-time/family replacement donors has continued to be 
a challenge in the sub-Saharan African region due to com-
mercial blood donors masquerading as family replacement 
donors. More stringent criteria for donor selection will help in 
the production of quality components for transfusion recipi-
ents in Nigeria. This study, however, does not postulate the 
existence of comorbid conditions with anemia, but instead 
represents an observation of a cross section of blood donors 
and provides a foundation for future studies.
The average adult male has about 7500 WBCs/mm3. This 
number may increase drastically following an infection and 
may decrease in people with an immunodeficiency disease 
such as AIDS.21 A low WBC count is referred to as leukopenia. 
Deficiency of all types of WBCs can be caused by bone mar-
row suppression; however, when there is selective reduction, 
the specific type of WBCs involved needs to be discussed. It 
should be noted that the donors were screened only for HIV 
and hepatitis B surface antigen. Other infectious agents or 
disease conditions that do not form part of our donor selection 
criteria may also lead to occult subclinical leukopenia. More 
studies on infectious agents and disease conditions (etiologi-
cal factors) prevalent in our locality need to be undertaken to 
unravel the causes of this subclinical leukopenia.
A reduction in the number of lymphocytes in the blood is 
often referred to as lymphocytopenia or lymphopenia. This 
condition may result from bone marrow suppression that 
affects all types of blood cells, but there are also specific 
deficiencies of B- and T-cells.22 Lymphocytopenia may be 
caused by lack of the trace element zinc, long-term heavy 
alcohol consumption, and certain infectious diseases such 
as HIV , viral hepatitis, influenza, and tuberculosis.21,23 In 
addition, B- and T-cells may fail to differentiate from their 
common precursor cell.21
Granulocytes are a class of WBCs that contain granules 
of chemicals. The three types of granulocytes are neutrophils, 
eosinophils, and basophils. Mast cells are tissue-based cells 
related to basophils. Granulocytes are produced and stored in 
the bone marrow until they are released by cytokines. These 
cells defend against bacteria, fungi, parasites, and allergens.24
Since we have been unable to find any reports on the 
effect of blood donation on WBCs, it is difficult to cor-
roborate the findings in this study; however, the significant 
reduction in lymphocyte counts among the leukopenic blood 
donors is an indication that their immune system may have 
been compromised. We recommend that regular eligibility 
screening for blood donation should include WBC counts, 
especially for those donating blood for component prepara-
tion of concentrated WBCs.
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